TENCENT (00700) spent approximately HK$100 million to repurchase 237,000 shares on September 18.
Tencent Holdings (00700) announced that on September 18, 2026, the company spent approximately HK$100 million to repurchase 237,000 shares at a price of HK$425.2 to HK$430.2 per share.
TENCENT (00700) announced that on September 18, 2026, the company spent approximately HK$100 million to repurchase 237,000 shares at a price of HK$425.2 to HK$430.2 per share.
Related Articles
IMPACT THERAP-B (07630): Senaparib receives positive CHMP opinion, expected to be used for first-line maintenance treatment of advanced epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
TRANSTHERA-B (02617): Jienntai (tinengotinib) included in the CSCO Guidelines for the Diagnosis and Treatment of Biliary Tract Malignancies (2026)
IMAGI INT'L-500 (00585): Tam Man Hong Appointed as Chairman of the Audit Committee
IMPACT THERAP-B (07630): Senaparib receives positive CHMP opinion, expected to be used for first-line maintenance treatment of advanced epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
TRANSTHERA-B (02617): Jienntai (tinengotinib) included in the CSCO Guidelines for the Diagnosis and Treatment of Biliary Tract Malignancies (2026)
IMAGI INT'L-500 (00585): Tam Man Hong Appointed as Chairman of the Audit Committee
RECOMMEND
